ShangPharma opens pilot plant in Shanghai

Published: 17-Jan-2011
Design & Build Manufacturing Regulatory Research & Development Cleaning Analysis Pharmaceutical

For pharma development and cGMP manufacturing

ShangPharma Corporation, a China-based contract research and manufacturing organisation, has started operations at a new manufacturing facility in the Shanghai suburb of Fengxian.

The new multi-purpose pharmaceutical development and cGMP manufacturing facility will allow ShangPharma to support its clients Phase II and Phase III trials, expanding its service offering to include process and formulation r&d, analytical method development and validation, and cGMP manufacturing of intermediates and APIs.

Previously the CRO/CMO provided clients with materials for early discovery and GLP toxicology testing and Phase I clinical trials.

ShangPharma said it might further expand its manufacturing facilities if there is demand for commercial manufacturing of FDA- or EMEA-approved drugs.

The Fengxian facility will operate as a wholly owned subsidiary of the company under the name China Gateway Pharmaceutical Development Co. It includes a pilot plant that supports six separate bays with reactor capacities ranging from 200 to 3,000 litres and other speciality bays with reactor capacities ranging from 50 to 2000 litres for high temperature, cryogenics, highly toxic and pressurised reactions, including hydrogenation.

The company said there are also two cleanroom suites rated at Class 100,000 for isolation, 10 kilo-lab suites for bothnon-cGMP and cGMP manufacturing, as well as a large r&d laboratory for analytical, formulation and process development activities.

In addition, there are separate buildings for utilities, materials management, warehouse storage and waste water treatment with room for further expansion to support commercial manufacturing activities.

Testing of raw materials, intermediates and final products will be carried out at the site. An independent quality assurance department will ensure that materials are manufactured in accordance with cGMP requirements and that established standard operating procedures are followed, the firm said.

See more

You may also like

Analysis

Beckman Coulter Life Sciences Introduces the Biomek i3 Benchtop Liquid Handler

Read more
A small but mighty addition to its portfolio of automated workstations

Trending Articles

  1. Cellipont Bioservices completes ballroom-style cleanroom for cell therapy production The Texas-based contract development and manufacturing organisation (CDMO) has completed a new cleanroom for allogeneic cell therapy production
  2. BAM wins build of pilot plant for photonic chips The construction expert has announced it will build a pilot plant for the production of photonic chips at the High Tech Campus Eindhoven, a milestone in Europe’s push for chip sovereignty
  3. FDA recalls ByHeart Infant Formula amid infant botulism outbreak The US Food and Drug Administration (FDA) has begun investigations into manufacturing controls and cleanroom practices after infant botulism outbreak
  4. Vileda Professional CE launches revolutionary single-use microfibre mopping system Vileda Professional CE launches revolutionary single-use microfibre mopping system for cleanrooms and controlled environments

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Analysis

Beckman Coulter Life Sciences Introduces the Biomek i3 Benchtop Liquid Handler

A small but mighty addition to its portfolio of automated workstations
Design & Build

Airkey expands manufacturing capabilities with new factory and faster delivery

After a strategic relocation and one-month intensive setup period, the company has resumed operations with enhanced capabilities, immediately demonstrating its upgraded capacity by completing a state-of-the-art ISO 5 cleanroom for an American food supplement manufacturer within just 15 days of restarting production
Design & Build

Novartis cuts 550 jobs at Stein site in Switzerland reshuffle

The pharmaceutical company has cut 550 jobs at its Stein site, while investing $80m in Schweizerhalle, after US tariffs are reduced on Swiss goods
Design & Build

Cleanroom expert ClearSphere secures €6m to drive UK and Ireland expansion

The cleanroom and containment specialist has secured funding from BGF to accelerate growth, expand capabilities and scale operations
Cleaning

Vileda Professional CE launches revolutionary single-use microfibre mopping system

Vileda Professional CE launches revolutionary single-use microfibre mopping system for cleanrooms and controlled environments
Hi Tech Manufacturing

FDA recalls ByHeart Infant Formula amid infant botulism outbreak

The US Food and Drug Administration (FDA) has begun investigations into manufacturing controls and cleanroom practices after infant botulism outbreak
Design & Build

Cellipont Bioservices completes ballroom-style cleanroom for cell therapy production

The Texas-based contract development and manufacturing organisation (CDMO) has completed a new cleanroom for allogeneic cell therapy production
Subscribe now